Tarsus Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US87650L1035

Introduction

This page provides a comprehensive analysis of the known insider trading history of Azamian Bobak R.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Azamian Bobak R. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:TARS / Tarsus Pharmaceuticals, Inc. President/CEO and Board Chair, Director 818,106
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Azamian Bobak R.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases TARS / Tarsus Pharmaceuticals, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in TARS / Tarsus Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TARS / Tarsus Pharmaceuticals, Inc. Insider Trades
Insider Sales TARS / Tarsus Pharmaceuticals, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in TARS / Tarsus Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-03-20 TARS Azamian Bobak R. 8,534 50.1100 8,534 50.1100 427,639 133 38.8200 -96,348 -22.53
2025-03-19 TARS Azamian Bobak R. 8,551 47.4000 8,551 47.4000 405,317
2025-03-18 TARS Azamian Bobak R. 7,131 46.2900 7,131 46.2900 330,094
2024-03-18 TARS Azamian Bobak R. 10,415 30.6000 10,415 30.6000 318,699
2023-03-23 TARS Azamian Bobak R. 737 12.1500 737 12.1500 8,955
2023-03-22 TARS Azamian Bobak R. 709 12.6400 709 12.6400 8,962
2023-03-21 TARS Azamian Bobak R. 679 12.8900 679 12.8900 8,752
2023-03-20 TARS Azamian Bobak R. 741 12.6100 741 12.6100 9,344
2023-03-17 TARS Azamian Bobak R. 795 13.2800 795 13.2800 10,558
2023-03-16 TARS Azamian Bobak R. 791 13.4300 791 13.4300 10,623

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TARS / Tarsus Pharmaceuticals, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Azamian Bobak R. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-08-13 2025-08-11 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,000 818,106 -0.73 50.00 -300,000 40,905,300
2025-03-26 2025-03-24 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,000 824,106 -0.72 50.00 -300,000 41,205,300
2025-03-20 2025-03-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale -8,534 53,635 -13.73 50.11 -427,639 2,687,650
2025-03-20 2025-03-19 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale -8,551 62,169 -12.09 47.40 -405,317 2,946,811
2025-03-20 2025-03-18 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale -7,131 70,720 -9.16 46.29 -330,094 3,273,629
2025-03-18 2025-03-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
M - Exercise 51,395 77,851 194.27
2024-03-19 2024-03-18 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale -10,415 26,456 -28.25 30.60 -318,699 809,554
2024-03-19 2024-03-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
M - Exercise 28,274 36,871 328.88
2023-12-29 2023-12-27 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -8,000 830,106 -0.95 20.22 -161,760 16,784,743
2023-12-22 2023-12-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -30,557 838,106 -3.52 20.36 -622,141 17,063,838
2023-12-22 2023-12-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -9,443 868,663 -1.08 19.96 -188,482 17,338,513
2023-11-17 2023-11-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -200 878,106 -0.02 19.28 -3,856 16,929,884
2023-11-17 2023-11-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -4,904 878,306 -0.56 18.54 -90,920 16,283,793
2023-11-17 2023-11-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -2,896 883,210 -0.33 18.01 -52,157 15,906,612
2023-10-20 2023-10-18 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -8,000 886,106 -0.89 13.24 -105,920 11,732,043
2023-09-22 2023-09-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -8,000 894,106 -0.89 17.21 -137,680 15,387,564
2023-08-25 2023-08-23 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -8,000 902,106 -0.88 17.23 -137,840 15,543,286
2023-07-21 2023-07-19 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -99,726 910,106 -9.88 20.04 -1,998,509 18,238,524
2023-07-21 2023-07-19 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -4,174 1,009,832 -0.41 19.28 -80,475 19,469,561
2023-07-14 2023-07-12 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -9,000 1,014,006 -0.88 17.35 -156,150 17,593,004
2023-06-23 2023-06-21 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -8,000 1,023,006 -0.78 18.63 -149,040 19,058,602
2023-06-16 2023-06-14 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -9,000 1,031,006 -0.87 18.58 -167,220 19,156,091
2023-06-12 2023-06-08 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -3,100 1,040,006 -0.30 20.01 -62,031 20,810,520
2023-05-19 2023-05-17 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -8,000 1,043,106 -0.76 15.90 -127,200 16,585,385
2023-05-12 2023-05-10 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -9,000 1,051,106 -0.85 16.80 -151,200 17,658,581
2023-05-02 2023-05-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -5,841 1,060,106 -0.55 15.10 -88,199 16,007,601
2023-05-02 2023-04-28 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -4,278 1,065,947 -0.40 15.13 -64,726 16,127,778
2023-04-25 2023-04-21 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -2,311 1,070,225 -0.22 15.03 -34,734 16,085,482
2023-04-21 2023-04-19 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -8,000 1,072,536 -0.74 13.60 -108,800 14,586,490
2023-03-23 2023-03-23 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale -737 8,597 -7.90 12.15 -8,955 104,454
2023-03-23 2023-03-22 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale -709 9,334 -7.06 12.64 -8,962 117,982
2023-03-23 2023-03-21 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale -679 10,043 -6.33 12.89 -8,752 129,454
2023-03-21 2023-03-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale -741 10,722 -6.46 12.61 -9,344 135,204
2023-03-21 2023-03-17 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale -795 11,463 -6.49 13.28 -10,558 152,229
2023-03-17 2023-03-16 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale -791 12,258 -6.06 13.43 -10,623 164,625
2023-03-17 2023-03-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
M - Exercise 11,299 13,049 645.66
2023-03-17 2023-03-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -8,000 1,080,536 -0.73 13.79 -110,320 14,900,591
2023-03-10 2023-03-09 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -717 1,088,536 -0.07 15.01 -10,762 16,338,925
2023-03-10 2023-03-08 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -4,853 1,089,253 -0.44 15.02 -72,892 16,360,580
2023-02-17 2023-02-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -8,000 1,094,106 -0.73 15.28 -122,240 16,717,940
2023-02-10 2023-02-08 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -9,000 1,102,106 -0.81 15.14 -136,260 16,685,885
2023-01-25 2023-01-23 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -4,856 1,111,106 -0.44 15.45 -75,025 17,166,588
2023-01-24 2023-01-06 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -411 1,129,740 -0.04 15.00 -6,165 16,946,100
2023-01-20 2023-01-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -240 1,116,373 -0.02 15.00 -3,600 16,745,595
2023-01-20 2023-01-18 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -8,000 1,116,613 -0.71 14.56 -116,480 16,257,885
2023-01-13 2023-01-11 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -3,904 1,124,613 -0.35 15.11 -58,989 16,992,902
2023-01-11 2023-01-10 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -905 1,128,517 -0.08 15.17 -13,729 17,119,603
2023-01-11 2023-01-09 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -729 1,129,422 -0.06 15.15 -11,044 17,110,743
2022-12-22 2022-12-21 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -8,000 1,130,151 -0.70 14.57 -116,560 16,466,300
2022-12-20 2022-12-16 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -535 1,138,151 -0.05 15.01 -8,030 17,083,647
2022-12-16 2022-12-14 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,420 1,138,686 -0.56 15.08 -96,814 17,171,385
2022-11-18 2022-11-16 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -745 1,145,106 -0.07 17.31 -12,896 19,821,785
2022-11-18 2022-11-16 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -7,255 1,145,851 -0.63 16.81 -121,957 19,261,755
2022-11-14 2022-11-09 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -9,000 1,153,106 -0.77 17.87 -160,830 20,606,004
2022-10-21 2022-10-19 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 1,162,106 -0.01 17.60 -1,760 20,453,066
2022-10-21 2022-10-19 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -7,900 1,162,206 -0.68 16.91 -133,589 19,652,903
2022-10-14 2022-10-12 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -2,821 1,170,106 -0.24 16.24 -45,813 19,002,521
2022-10-14 2022-10-12 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,179 1,172,927 -0.52 15.76 -97,381 18,485,330
2022-09-23 2022-09-21 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 1,179,106 -0.01 17.04 -1,704 20,097,862
2022-09-23 2022-09-21 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -7,900 1,179,206 -0.67 16.30 -128,770 19,221,058
2022-09-16 2022-09-14 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -9,000 1,187,106 -0.75 16.01 -144,090 19,005,567
2022-08-19 2022-08-17 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -736 1,196,106 -0.06 17.44 -12,836 20,860,089
2022-08-19 2022-08-17 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -7,264 1,196,842 -0.60 16.50 -119,856 19,747,893
2022-03-11 2022-03-09 4 TARS Tarsus Pharmaceuticals, Inc.
Restricted Stock Units
A - Award 45,197 45,197
2022-03-11 2022-03-09 4 TARS Tarsus Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 154,067 154,067
2021-12-03 2021-12-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -578 1,204,106 -0.05 26.76 -15,467 32,221,877
2021-12-03 2021-12-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -760 1,204,684 -0.06 25.90 -19,684 31,201,316
2021-12-03 2021-12-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -2,101 1,205,444 -0.17 24.70 -51,895 29,774,467
2021-12-03 2021-12-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -2,394 1,207,545 -0.20 23.86 -57,121 28,812,024
2021-11-03 2021-11-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -800 1,209,939 -0.07 28.21 -22,568 34,132,379
2021-11-03 2021-11-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -5,033 1,210,739 -0.41 27.76 -139,716 33,610,115
2021-10-14 2021-10-12 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -4,698 1,215,772 -0.38 26.44 -124,215 32,145,012
2021-10-14 2021-10-12 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -833 1,220,470 -0.07 25.49 -21,233 31,109,780
2021-10-12 2021-10-08 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -302 1,221,303 -0.02 25.02 -7,555 30,554,558
2021-09-03 2021-09-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 1,221,605 -0.01 26.40 -2,640 32,250,372
2021-09-03 2021-09-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -5,733 1,221,705 -0.47 25.23 -144,661 30,827,282
2021-08-12 2021-08-11 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -1,917 1,227,438 -0.16 25.07 -48,061 30,773,098
2021-08-12 2021-08-10 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -103 1,229,355 -0.01 25.00 -2,575 30,733,875
2021-08-10 2021-08-09 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 1,229,458 -0.01 25.13 -2,513 30,896,280
2021-08-10 2021-08-09 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -727 1,229,558 -0.06 25.00 -18,175 30,738,950
2021-08-10 2021-08-06 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -1,616 1,230,285 -0.13 25.00 -40,400 30,757,125
2021-08-06 2021-08-05 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale X -1,370 1,231,901 -0.11 25.00 -34,250 30,797,525
2021-01-08 2021-01-07 4 TARS Tarsus Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 204,998 204,998
2020-10-20 2020-10-20 4 TARS Tarsus Pharmaceuticals, Inc.
Series B Preferred Stock
C - Conversion -1,750 0 -100.00
2020-10-20 2020-10-20 4 TARS Tarsus Pharmaceuticals, Inc.
Series A Preferred Stock
C - Conversion -21,575 0 -100.00
2020-10-20 2020-10-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
C - Conversion 1,750 1,750
2020-10-20 2020-10-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
C - Conversion 21,575 1,233,271 1.78
2020-10-15 3 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
1,211,696
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)